Oncology Medical News about metallopanstimulin-1

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Extraribosomal function of metallopanstimulin-1: Reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth
International Journal of Cancer, 11/05/09

Dai Y et al. – These data indicate that when MPS–1 is overexpressed, it has an extraribosomal function as a strong inhibitor of HNSCC tumor cell growth, which may be exerted by reduced paxillin gene expression.

Exclusive Author Commentary
Brendan C. Stack, 11/05/09

This article represents a first for consideration of the use of ribosomal proteins as a possible therapy for head and neck cancer. Ribosomal proteins are integral actors in cancer molecular biology. This class of peptides may offer new therapeutic options for many types of malignacies.

<< Previous
Genetic variation in CYP17A1 and pancreatic cancer in a...

Next >>
Iron-Fortified Rice Is As Efficacious As Supplemental Iron Drops...